Abstract:
ob<x>jective: To investigate the relationship between serum thioredoxin (Trx) and thioredoxin reductase (TrxR) levels and early neurological deterioration (END) in patients with acute cerebral infarction. Methods: A total of 156 patients with acute cerebral infarction admitted to our hospital from January 1, 2020 to December 31, 2021 were selected as the research group, and were divided into END group (n=68) and non-END group (n=88) according to whether END occurred or not, and 70 healthy volunteers who underwent physical examination in our hospital during the same period were used as the control group. Serum Trx and TrxR levels were detected by enzyme-li<x>nked immunosorbent assay after admission in all included subjects. The clinical ba<x>seline data and serum Trx and TrxR levels of each group were analyzed and compared. The receiver operating characteristic curve (ROC) and area under the curve (AUC) was used to analyze the predictive value of Trx and TrxR on END in acute cerebral infarction. The related factors affecting END in acute cerebral infarction were analyzed by multivariate logistic regression analysis. Results: The serum Trx level in the study group was higher compared with control group ( P<0.05), and the serum TrxR level was lower compared wit control group ( P<0.05). The serum Trx and TrxR levels in the END group were higher than those in the non-END group (P<0.05). The results of the ROC curve showed that the areas under the curve of Trx and TrxR for predicting END of acute cerebral infarction were 0.802 and 0.830, respectively, the cut-off values were 12.30 ng/ml and 1.95 U/mL, and the sensitivity was 80.63% and 79.21%, and the specificity were 85.66% and 89.85%, respectively. The area under the curve of the two combined to predict the occurrence of END in acute cerebral infarction was 0.910, the sensitivity was 90.88%, and the specificity was 82.31%. Multivariate logistic regression analysis showed that serum Trx, TrxR levels and NHISS scores were risk factors for END in acute cerebral infarction( P<0.05). Conclusion: Serum levels of Trx increased and TrxR levels decreased in patients with acute cerebral infarction. Serum levels of Trx and TrxR are both decreased in patients with END. Both are influencing factors of END in patients with acute cerebral infarction, and can be used as clinical evaluation indicators for END in patients with acute cerebral infarction